T1	CHEM 46 56	Fluconazol
#1	AnnotatorNotes T1	C0016277; fluconazole; Organic Chemical · Pharmacologic Substance
T2	CHEM 66 77	micafungina
#2	AnnotatorNotes T2	C1120386; micafungin; Amino Acid, Peptide, or Protein · Antibiotic
T3	CHEM 112 122	Fluconazol
#3	AnnotatorNotes T3	C0016277; fluconazole; Organic Chemical · Pharmacologic Substance
T4	CHEM 132 143	micafungina
#4	AnnotatorNotes T4	C1120386; micafungin; Amino Acid, Peptide, or Protein · Antibiotic
T5	DISO 160 171	candidiasis
#5	AnnotatorNotes T5	C0006840; Candidiasis; Disease or Syndrome
T6	PROC 187 194	cultivo
#6	AnnotatorNotes T6	C0430400; Laboratory culture; Laboratory Procedure
T7	PROC 196 246	estudio randomizado de fármacocinética y seguridad
T8	DISO 296 307	candidiasis
#7	AnnotatorNotes T8	C0006840; Candidiasis; Disease or Syndrome
T9	PROC 310 317	cultivo
#8	AnnotatorNotes T9	C0430400; Laboratory culture; Laboratory Procedure
T10	PROC 488 496	cultivos
#9	AnnotatorNotes T10	C0430400; Laboratory culture; Laboratory Procedure
T11	PROC 514 537	tratamiento antifúngico
T12	DISO 610 621	candidiasis
#10	AnnotatorNotes T12	C0006840; Candidiasis; Disease or Syndrome
T13	PROC 629 636	cultivo
#11	AnnotatorNotes T13	C0430400; Laboratory culture; Laboratory Procedure
T15	CHEM 836 846	medicación
#12	AnnotatorNotes T15	C0013227; Pharmaceutical Preparations; Pharmacologic Substance | C0456386; Medicament; Pharmacologic Substance
T16	PROC 864 908	monitorización de las variables de seguridad
T17	PROC 964 974	profilaxis
#13	AnnotatorNotes T17	C0199176; Prophylactic treatment; Therapeutic or Preventive Procedure
T18	CHEM 992 1003	micafungina
#14	AnnotatorNotes T18	C1120386; micafungin; Amino Acid, Peptide, or Protein · Antibiotic
T19	CHEM 1054 1066	antifúngicos
#15	AnnotatorNotes T19	C0003308; Antifungal Agents; Pharmacologic Substance
T20	DISO 1118 1139	infección por cándida
#16	AnnotatorNotes T20	C0006840; Candidiasis; Disease or Syndrome
T21	DISO 1355 1384	co-infectado con un organismo
T22	DISO 1433 1450	hipersensibilidad
#17	AnnotatorNotes T22	C0020517; Hypersensitivity; Pathologic Function | C0429891; Hypersensitivity finding; Finding
T23	CHEM 1508 1518	fluconazol
#18	AnnotatorNotes T23	C0016277; fluconazole; Organic Chemical · Pharmacologic Substance
T24	DISO 1533 1560	enfermedad hepática o renal
T25	ANAT 1555 1560	renal
#19	AnnotatorNotes T25	C0022646; Kidney; Body Part, Organ, or Organ Component | C1278978; Entire kidney; Body Part, Organ, or Organ Component
T26	LIVB 81 89	neonatos
#20	AnnotatorNotes T26	C0021289; Infant, Newborn; Age Group
T27	LIVB 147 155	neonatos
#21	AnnotatorNotes T27	C0021289; Infant, Newborn; Age Group
T28	LIVB 271 279	Neonatos
#22	AnnotatorNotes T28	C0021289; Infant, Newborn; Age Group
T29	LIVB 355 363	Neonatos
#23	AnnotatorNotes T29	C0021289; Infant, Newborn; Age Group
T30	CHEM 526 537	antifúngico
#24	AnnotatorNotes T30	C0003308; Antifungal Agents; Pharmacologic Substance
T31	PROC 659 681	Consentimiento escrito
#25	AnnotatorNotes T31	C0811746; Obtain written consent; Health Care Activity
T32	PROC 815 846	administración de la medicación
T33	CHEM 979 989	fluconazol
#26	AnnotatorNotes T33	C0016277; fluconazole; Organic Chemical · Pharmacologic Substance
T34	DISO 1158 1180	patología concomitante
T35	CHEM 1492 1505	equinocándida
#27	AnnotatorNotes T35	 C1268551; Echinocandins; Pharmacologic Substance
T36	DISO 1453 1472	reacción vasomotora
T37	ANAT 1544 1552	hepática
#28	AnnotatorNotes T37	C0023884; Liver; Body Part, Organ, or Organ Component | C1278929; Entire liver; Body Part, Organ, or Organ Component
T38	Date 13 17	2012
T41	Spec_cue 174 182	sospecha
T43	Spec_cue 284 295	sospecha de
T45	LIVB 366 371	niños
#29	AnnotatorNotes T45	C0008059; Child; Age Group
T46	Duration 372 393	entre 24 y 42 semanas
T47	PHYS 397 406	gestación
#30	AnnotatorNotes T47	C0032961; Pregnancy; Organism Function
T48	Date 420 429	postnatal
T49	Age 433 441	48 horas
T50	Spec_cue 590 598	sospecha
T51	LIVB 648 655	cándida
#31	AnnotatorNotes T51	C0006836; Candida (fungus); Fungus
T52	LIVB 689 695	padres
#32	AnnotatorNotes T52	C0015671; Father (person); Family Group | C0030551; parent; Family Group
T53	LIVB 698 720	representantes legales
#33	AnnotatorNotes T53	C4288823; Legal Representative for the Study; Human
T54	LIVB 757 761	niño
#34	AnnotatorNotes T54	C0008059; Child; Age Group
T55	LIVB 938 943	Niños
#35	AnnotatorNotes T55	C0008059; Child; Age Group
T56	LIVB 1029 1034	Niños
#36	AnnotatorNotes T56	C0008059; Child; Age Group
T57	Duration 1099 1109	más de 48h
T58	LIVB 1143 1148	Niños
#37	AnnotatorNotes T58	C0008059; Child; Age Group
T59	LIVB 1208 1220	investigador
#38	AnnotatorNotes T59	C0035173; Research Personnel; Professional or Occupational Group
T62	LIVB 1300 1305	Niños
#39	AnnotatorNotes T62	C0008059; Child; Age Group
T63	LIVB 1349 1354	Niños
#40	AnnotatorNotes T63	C0008059; Child; Age Group
T64	LIVB 1375 1384	organismo
#41	AnnotatorNotes T64	C0029235; Organism; Organism
T65	LIVB 1400 1407	cándida
#42	AnnotatorNotes T65	C0006836; Candida (fungus); Fungus
T66	LIVB 1411 1416	Niños
#43	AnnotatorNotes T66	C0008059; Child; Age Group
T67	LIVB 1523 1528	Niños
#44	AnnotatorNotes T67	C0008059; Child; Age Group
T68	LIVB 1132 1139	cándida
#45	AnnotatorNotes T68	C0006836; Candida (fungus); Fungus
T39	Neg_cue 1385 1396	diferente a
T40	DEVI 776 789	acceso venoso
#46	AnnotatorNotes T40	C0750164; venous access; Medical Device
T42	PHYS 219 234	fármacocinética
#47	AnnotatorNotes T42	C0031327; Drug Kinetics; Physiologic Function
T14	PROC 573 587	microbiológico
A1	Assertion T5 Speculated
A2	Population_data T45 Age
A3	Assertion T8 Speculated
A4	Assertion T12 Speculated
A5	Population_data T62 Age
A6	Population_data T63 Age
A7	Population_data T66 Age
A8	Population_data T67 Age
A9	Population_data T58 Age
A10	Population_data T56 Age
A11	Population_data T55 Age
A12	Population_data T54 Age
A13	Assertion T65 Negated
A14	Population_data T29 Age
A15	Population_data T28 Age
A16	Population_data T26 Age
A17	Population_data T27 Age
A18	Status T22 History_of
A19	Status T36 History_of
#48	AnnotatorNotes T7	C0034656; Randomization; Research Activity + C0201734; Pharmacokinetic study; Research Activity + C1705187; Safety Study; Research Activity
#49	AnnotatorNotes T11	C2363963; Antifungal treatment; Therapeutic or Preventive Procedure 
#50	AnnotatorNotes T32	C3469597; Administration of medication; Therapeutic or Preventive Procedure
#51	AnnotatorNotes T34	C0243087; concomitant disease; Pathologic Function
#52	AnnotatorNotes T24	C0022658; Kidney Diseases; Disease or Syndrome + C0023895; Liver diseases; Disease or Syndrome
T44	Spec_cue 1221 1226	pueda
T60	Observation 1278 1284	riesgo
A20	Assertion T60 Speculated
R1	Speculation Arg1:T44 Arg2:T60	
T61	Observation 1240 1263	participar en el ensayo
#53	AnnotatorNotes T61	C1278516; Patient participation status; Finding
R2	Overlap Arg1:T61 Arg2:T60	
R4	Experiences Arg1:T58 Arg2:T60	
T69	Observation 1306 1345	incluidos anteriormente en este estudio
A21	Status T69 History_of
#54	AnnotatorNotes T69	C2242969; clinical trial participant (history); Finding (?)
R5	Negation Arg1:T39 Arg2:T65	
R6	Causes Arg1:T64 Arg2:T21	
#55	AnnotatorNotes T21	C0275524; Coinfection; Disease or Syndrome
R7	Experiences Arg1:T63 Arg2:T21	
R8	Has_Quantifier_or_Qualifier Arg1:T62 Arg2:T69	
R9	Experiences Arg1:T66 Arg2:T22	
R10	Experiences Arg1:T66 Arg2:T36	
R11	Causes Arg1:T35 Arg2:T22	
R12	Causes Arg1:T23 Arg2:T22	
R13	Causes Arg1:T23 Arg2:T36	
R14	Causes Arg1:T23 Arg2:T22	
T70	Quantifier_or_Qualifier 1473 1479	severa
#56	AnnotatorNotes T70	C1547227; Severe - Severity of Illness Code; Intellectual Product
R15	Has_Quantifier_or_Qualifier Arg1:T36 Arg2:T70	
R16	Location_of Arg1:T25 Arg2:T24	
R17	Location_of Arg1:T37 Arg2:T24	
R18	Experiences Arg1:T67 Arg2:T24	
R19	Experiences Arg1:T26 Arg2:T1	
R20	Experiences Arg1:T26 Arg2:T2	
R23	Experiences Arg1:T27 Arg2:T5	
R24	Speculation Arg1:T41 Arg2:T5	
R26	Experiences Arg1:T27 Arg2:T6	
R27	Experiences Arg1:T27 Arg2:T3	
R28	Experiences Arg1:T27 Arg2:T4	
R29	Experiences Arg1:T27 Arg2:T42	
R30	Experiences Arg1:T28 Arg2:T8	
R31	Experiences Arg1:T28 Arg2:T9	
R32	Speculation Arg1:T43 Arg2:T8	
T71	Result_or_Value 318 326	positivo
#57	AnnotatorNotes T71	C1446409; Positive; Finding
R33	Has_Result_or_Value Arg1:T9 Arg2:T71	
R34	Has_Duration_or_Interval Arg1:T47 Arg2:T46	
R35	Has_Age Arg1:T45 Arg2:T49	
R36	Has_Age Arg1:T29 Arg2:T49	
R37	Overlap Arg1:T10 Arg2:T49	
R38	Overlap Arg1:T10 Arg2:T48	
R39	Used_for Arg1:T30 Arg2:T11	
R40	Speculation Arg1:T50 Arg2:T12	
#58	AnnotatorNotes T14	C0085672; Microbiology procedure; Laboratory Procedure
R41	Before Arg1:T14 Arg2:T11	
T72	Result_or_Value 637 645	positivo
#59	AnnotatorNotes T72	C1446409; Positive; Finding
R42	Has_Result_or_Value Arg1:T13 Arg2:T72	
R43	Causes Arg1:T51 Arg2:T72	
R44	Causes Arg1:T51 Arg2:T12	
R45	Overlap Arg1:T12 Arg2:T13	
R46	Overlap Arg1:T12 Arg2:T72	
R47	Before Arg1:T13 Arg2:T11	
R48	Before Arg1:T72 Arg2:T11	
T73	PROC 744 750	ensayo
#60	AnnotatorNotes T73	C0008972; Clinical Research; Research Activity | C0008976; Clinical Trials; Research Activity
R49	Before Arg1:T31 Arg2:T73	
T74	Observation 776 799	acceso venoso aceptable
R50	Experiences Arg1:T54 Arg2:T40	
R51	Used_for Arg1:T40 Arg2:T32	
R52	Overlap Arg1:T74 Arg2:T32	
R53	Used_for Arg1:T15 Arg2:T32	
R54	Experiences Arg1:T54 Arg2:T32	
R55	Experiences Arg1:T54 Arg2:T16	
R56	Overlap Arg1:T74 Arg2:T16	
R57	Experiences Arg1:T55 Arg2:T17	
A22	Status T17 History_of
R58	Used_for Arg1:T33 Arg2:T17	
A23	Status T33 History_of
A24	Status T18 History_of
R59	Used_for Arg1:T18 Arg2:T17	
T75	CONC 1016 1025	inclusión
#62	AnnotatorNotes T75	C1512693; Inclusion; Qualitative Concept
R60	Before Arg1:T17 Arg2:T75	
R61	Experiences Arg1:T56 Arg2:T19	
A25	Status T19 History_of
R62	Has_Duration_or_Interval Arg1:T19 Arg2:T57	
R63	Causes Arg1:T68 Arg2:T20	
R64	Experiences Arg1:T56 Arg2:T20	
T76	Quantifier_or_Qualifier 1067 1077	sistémicos
#63	AnnotatorNotes T76	C0205373; Systemic; Functional Concept
R65	Has_Quantifier_or_Qualifier Arg1:T19 Arg2:T76	
A26	Status T76 History_of
R66	Experiences Arg1:T58 Arg2:T34	
R67	Before Arg1:T34 Arg2:T61	
T77	Quantifier_or_Qualifier 1285 1296	inaceptable
A27	Assertion T77 Speculated
#64	AnnotatorNotes T77	C1883420; Unacceptable; Qualitative Concept
R68	Has_Quantifier_or_Qualifier Arg1:T60 Arg2:T77	
R69	Speculation Arg1:T44 Arg2:T77	
#65	AnnotatorNotes T60	C0559571; At risk; Finding
R25	Overlap Arg1:T8 Arg2:T71	
R3	Before Arg1:T34 Arg2:T60	
#61	AnnotatorNotes T36	C0750152; vasomotor symptom; Sign or Symptom (?)
#66	AnnotatorNotes T16	C5235447; Safety Monitoring; Research Activity
A28	Experiencer T26 Patient
A29	Experiencer T27 Patient
A30	Experiencer T28 Patient
A31	Experiencer T29 Patient
A32	Experiencer T45 Patient
A33	Experiencer T52 Family_member
A34	Experiencer T53 Other
A35	Experiencer T54 Patient
A36	Experiencer T55 Patient
A37	Experiencer T56 Patient
A38	Experiencer T58 Patient
T78	LIVB 1199 1205	médico
#67	AnnotatorNotes T78	C0031831; Physicians; Professional or Occupational Group
A39	Experiencer T78 Other
A40	Experiencer T59 Other
A41	Experiencer T62 Patient
A42	Experiencer T63 Patient
A43	Experiencer T66 Patient
A44	Experiencer T67 Patient
